Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Obstructive Pulmonary Disease With Exacerbation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01114386
What this trial is testing

Clinical Assessment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and/or Chronic Heart Failure (CHF)

Who this might be right for
COPDHeart Failure, Congestive
University of Modena and Reggio Emilia 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT07587658
What this trial is testing

This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Regeneron Pharmaceuticals 754
Large-scale testing (Phase 3)Study completedNCT00274547
What this trial is testing

Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 1,829
Not applicableStudy completedNCT01108185
What this trial is testing

Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory Tract Infection

Who this might be right for
TracheitisTracheobronchitisBronchitis+2 more
Abbott 3,181
Not applicableUnknownNCT03940040
What this trial is testing

High Flow Nasal Oxygen Versus Usual Care in COPD Pulmonary Rehabiliation

Who this might be right for
Chronic Obstructive Pulmonary Disease
Changi General Hospital 22
Large-scale testing (Phase 3)Study completedNCT00076089
What this trial is testing

OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)

Who this might be right for
Chronic Obstructive Pulmonary DiseaseCOPD
AstraZeneca 1,100
Large-scale testing (Phase 3)Study completedNCT00649831
What this trial is testing

A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis

Who this might be right for
Bronchitis, Chronic
Pfizer 250
Not applicableStudy completedNCT01405222
What this trial is testing

Cough Frequency in Chronic Obstructive Pulmonary Disease

Who this might be right for
COPD Exacerbation
Hull University Teaching Hospitals NHS Trust 24
Post-approval studies (Phase 4)UnknownNCT04319705
What this trial is testing

Anti-viral Effects of Azithromycin in Patients With Asthma and COPD

Who this might be right for
AsthmaCOPDExacerbation Copd+5 more
Bispebjerg Hospital 100
Not applicableStudy completedNCT01745419
What this trial is testing

Prevalence of Different Haptoglobin Phenotypes in Patients With COPD- Frequent Exacerbators Versus Non Exacerbators

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Carmel Medical Center 105
Not applicableUnknownNCT05019911
What this trial is testing

Prediction of Exacerbations and Management of COPD Patients With SAH Based on Millimeter Wave Radar Monitoring

Who this might be right for
COPDSleep Apnea Hypopnea SyndromeAcute Exacerbation of COPD
Peking University Third Hospital 922
Not applicableStudy completedNCT03458364
What this trial is testing

Comparison of HFNC With NIV in Weaning COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation
Jie Li 42
Post-approval studies (Phase 4)Looking for participantsNCT07192016
What this trial is testing

129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Western University, Canada 60
Not applicableLooking for participantsNCT06198309
What this trial is testing

Risk Prediction Model for Exacerbating Phenotype in Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease Severe
Li An 365
Not applicableStudy completedNCT01987544
What this trial is testing

Effects of Ergometer Training With Telemonitoring in Patients With Chronic Obstructive Pulmonary Disease (COPD) After Exacerbation

Who this might be right for
COPD
Institut für Pneumologie Hagen Ambrock eV 53
Large-scale testing (Phase 3)Study completedNCT00259779
What this trial is testing

Comparison Between Symbicort® and Prednisolone in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 120
Post-approval studies (Phase 4)Study completedNCT01662986
What this trial is testing

Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 79
Post-approval studies (Phase 4)Study completedNCT02857842
What this trial is testing

Corticosteroid Reduction in COPD

Who this might be right for
Lung Diseases, ObstructiveBlood Eosinophil CountGlucocorticoids+2 more
Chronic Obstructive Pulmonary Disease Trial Network, Denmark 318
Not applicableWithdrawnNCT02107222
What this trial is testing

The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD)

Who this might be right for
COPDChronic Obstructive Pulmonary Disease
Maquet Cardiopulmonary GmbH
Large-scale testing (Phase 3)Study completedNCT01120691
What this trial is testing

Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals 2,224
Next Page